Macralytics CMS
Home
MIPS Measures
Specialty Measure Set:
Oncology/Hematology
Appropriate Germline Testing for Ovarian Cancer Patients
June 11, 2026
Positive PD-L1 Biomarker Expression Test Result Prior to First-Line Immune Checkpoint Inhibitor Therapy
June 11, 2026
Gains in Patient Activation Measure (PAM®) Scores at 12 Months
June 11, 2026
Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood
June 11, 2026
Adult Immunization Status
June 11, 2026
Appropriate Intervention of Immune-Related Diarrhea and/or Colitis in Patients Treated with Immune Checkpoint Inhibitors
June 11, 2026
Bone Density Evaluation for Patients with Prostate Cancer and Receiving Androgen Deprivation Therapy
June 11, 2026
Percentage of Patients who Died from Cancer Admitted to Hospice for Less than 3 Days (lower score – better)
June 11, 2026
Percentage of Patients Who Died from Cancer Receiving Systemic Cancer-Directed Therapy in the Last 14 Days of Life (lower score – better)
June 11, 2026
RAS (KRAS and NRAS) Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer Who Receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
June 11, 2026
1
2
3
Next Page
→